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Recently (1), we described a suspension culture procedure that permitted the 
exponential growth  of the progenitors of the blast  population  in acute  myelo- 
blastic  leukemia  (AML). 1 Changes  in  the  number  of progenitor  cells  in  such 
cultures was assessed  using a  colony assay for clonogenic cells (2).  Increases in 
blast progenitors were seen regularly, and in some instances,  the cells could be 
recultured, with the maintenance of exponential growth, for periods of weeks. 
In addition to standard growth medium (fetal calf serum [FCS] and a  minimum 
essential  medium  [a-MEM]),  there  were  two  requirements  for growth.  These 
were,  first,  the  presence  of  one  or  more  growth  factors  present  in  media 
conditioned either by leukocytes stimulated by phytohemagglutinin (PHA-LCM) 
(3), or by bladder carcinoma cells from the continuous line HTB9 (HTB9-CM) 
(4). Second, the cell density of the cultures had to be maintained at 106 cells/ml; 
the  latter  requirement  could  be  met  using  irradiated  cells  added  to  smaller 
numbers of intact blasts. 
In  this paper,  we describe  experiments designed to characterize the  feeding 
role of blast cells. We found that the capacity of blasts to support the growth of 
small numbers of progenitors was distributed heterogeneously among the pop- 
ulation.  We  also  found  that  cell  membranes  from  autologous or  homologous 
AML blasts could replace intact cells in supporting the growth of blast progenitors 
in  suspension  culture.  We  suggest  that  these  findings  may have an  important 
bearing on the regulation of blast cell proliferation. 
Materials and Methods 
Cell Sources.  Blasts were obtained with informed consent from the peripheral blood 
of five patients with AML, one with acute lymphoblastic leukemia (ALL), and one with 
chronic lymphocytic leukemia (CLL). The diagnosis was based on cell morphology using 
a previously-defined classification system (5);  normal marrow cells  were obtained from 
healthy marrow transplantation donors. 
Mononuclear cell fractions were prepared as described previously by separation through 
Ficoll-hypaque (density =  1.077 g/cm3; Winthrop Laboratories, Aurora, Canada).  The 
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suspension was then depleted of T  lymphocytes using a second Ficoll-Hypaque separation 
after  erythrocyte  rosette  formation.  The  T  cell-depleted  cells  were  either  cultured 
immediately or preserved by freezing in  liquid  nitrogen in  10%  dimethylsulfoxide and 
50% fetal calf serum. 
Blast Colony Assay.  The capacity of blast  progenitors to form colonies in culture was 
assessed  as  reported  previously (1,  6),  except  that  media  conditioned by cells  of the 
continuous bladder carcinoma line HTB9 (American Type Culture Collection, Rockville, 
MD) were used rather than PHA-LCM (4). Blast cell suspensions,  at a concentration of 4 
x  105 cells/ml in  1 ml of c~-MEM, 20% FCS,  10% HTB9-CM, and 0.8% methylcellulose 
were cultured in  35-mm Lux culture dishes  (Miles Laboratories,  Inc., Naperville,  IL). 
After 7 d incubation at 37°C in a humidified atmosphere of 5% CO2 in air,  colonies of 
>20 cells were counted. 
Liquid Suspension  Culture.  Blast progenitors were cultured in suspension as described 
previously (1). T  cell-depleted mononuclear cells from AML patients, at a concentration 
of 106 cells/ml were suspended in 3 ml of c~-MEM supplemented with 20%  FCS and 10% 
HTB9-CM. The cells were harvested and counted at day 7. The blast  plating efficiency 
was determined using the blast colony assay. The total yield of blast progenitors per dish 
was calculated from plating efficiency and cell recovery. 
Separation  of Cells  by  Velocity Sedimentation.  Blast  cells  were  separated  by  velocity 
sedimentation as previously described (7). Cells suspended in phosphate buffered saline 
(PBS) supplemented  with  0.2%  bovine serum  albumin  (BSA) were added to a  shallow 
buffered gradient consisting of 1-2% BSA in PBS. After 4 h sedimentation at 4°C, the 
cone  volume  was  discarded,  and  15.5-ml  fractions  were  collected.  Each  fraction  was 
concentrated to 1 ml by centrifugation, and the cells were counted. 
Cell Membrane  Preparation.  Cells were fractionated by a modification of the method 
of Bell et al. (8). Cells were washed in PBS and incubated in lysis buffer (10 mM KCI, 1.5 
mM MgCI2, 2 mM phenylmethylsulfonyl fluoride,  10 mM Tris-HCl, pH 7.4) at 4°C for 
30 rain.  Meanwhile,  cells were mixed at  10-min intervals.  Cells were ruptured in a Ten 
Broech homogenizer (Kontes Co., Vineland, N  J). Complete rupture was confirmed using 
phase-contrast microscopy. The homogenate was centrifuged at 400 g for 10 rain.  The 
pellet obtained consisted of nuclei.  The supernatant was centrifuged again at  35,000 g 
for 40 min. This pellet contained membranes and microsomes (referred to hereafter as 
the  membrane  fraction),  and  the  supernatant  was  considered as  fluid  cytoplasm. The 
three  fractions were  resuspended  quantitatively in  c~-MEM, so that the  number of cell 
equivalents per milliliter  was known. 
Statistics.  Group  data  were  compared  by  Student's  t  test.  Linear  regression  was 
determined by the method of least squares.  Data are presented as the mean + SE. 
Results 
Under optimal  conditions,  there  is  a  linear  relation  between  the  number  of 
intact  blast  cells  added  to  suspension  cultures  and  the  recovery of clonogenic 
cells  7  d  later.  This  relationship  is  shown  in  Fig.  1;  where  cell  density  was 
maintained  by  adding  irradiated  cells  and  growth  factors,  supplied  either  as 
HTB9-CM or  PHA-LCM, clonogenic cell  recovery increased  linearly with  the 
number of intact cells in the cultures.  HTB9-CM was,  however, more effective 
than PHA-LCM. In contrast, removing either HTB9-CM or irradiated cells from 
the cultures greatly reduced the yield of clonogenic progenitors; intact cells by 
themselves, without either feeders or a source of growth factors, were ineffective 
in generating new clonogenic cells. It is evident from the figure that both a high 
cell concentration and the presence of a source of growth factors were required; 
adding increased numbers of irradiated cells did not substitute for growth factors, 
nor was HTB9-CM sufficient by itself when irradiated  cells were omitted from 
the  cultures.  Thus,  the  data  depicted  in  Fig.  1  lead  to  three  conclusions:  (a) NARA  AND  McCULLOCH  1437 
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FIGURE  1.  Relationship between the number of intact cells added to cultures and recovery 
of clonogenic progenitors after 7 d. (V1) Cultures containing only intact cells. (I) Cultures with 
intact cells and sufficient irradiated autologous blasts to give a final concentration of 10  6 cells/ 
ml. (C)) Cultures with HTB9-CM added to intact cells. (A) Cultures with both irradiated cells 
and PHA-LCM. (0) Cultures with both irradiated cells and HTB9-CM. 
HTB9-CM can  replace  PHA-LCM as a  source of growth  factors in suspension 
culture system; (b) both growth factors and a  high  cell density are required for 
optimal growth, and (c) the linear relationship between input blast cell number 
and  clonogenic  cell  recovery  allows  the  method  to  be  used  in  quantitative 
experiments. 
Media Conditioned  by Blast Cells.  Previously (1), we observed that the addition 
of methylcellulose to suspension cultures of blast cells reduced the yield of new 
clonogenic progenitors, even when cell density was maintained. This observation 
was interpreted  to  indicate  that  cell  contact  was required.  Alternatively,  blast 
cells might secrete or shed growth factors that could act synergistically with those 
present in HTB9-CM. For the populations used in this study, we tested for this 
possibility by using supernatants  from 7-d blast cultures in the clonogenic assay. 
Results of a typical experiment are given in Fig. 2.  It is evident that HTB9-CM 
was a  very  effective growth  factor  for  blast  colonies.  The  addition  of media 
conditioned by blast cells also increased colony formation; however, the cultures 
used  to  produce  conditioned  media  contained  HTB9-CM.  Accordingly,  as  a 
control, HTB9-CM was incubated for 7 d in the absence of cells. It may be seen 
from  the  figure  that  this  material  was  as  effective  as  blast  cell-conditioned 
medium in stimulating colony formation.  It seems unlikely, therefore, that blast 1438  LEUKEMIC MEMBRANES STIMULATE  GROWTH 
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FIGURE 2.  Effect of increasing concentrations of conditioned medium on blast colony for- 
mation in methylcellulose. (0) Cultures with HTB9-CM. (A) Cultures with supernatants of 
blast suspension cultures. (O) Control cultures with HTB9-CM incubated for 7 d, as in the 
cultures containing blasts in suspension. 
cell-derived growth factors play an important role in the generation of new blast 
progenitors in suspensions.  Rather, the data support the view that cell contact is 
necessary. 
Separation of Blast Cells by Sedimentation  Velocity.  In the next series of experi- 
ments, we asked  whether all blasts were equally effective in providing support 
for growth. Blast populations were separated by sedimentation velocity. Fractions 
were assayed  for their content of blast cells and  their plating  efficiency in  the 
blast assay.  Other aliquots of each fraction were adjusted to a  concentration of 
3  x  105 cetls/ml,  irradiated,  and added  to suspension  cultures containing fi  x 
105 autologous intact blast cells. After 7 d, these cultures were harvested, washed, 
and the blast plating efficiency was determined. The data from one of two similar 
experiments are presented in Fig.  S. Fig.  S a  shows the distribution of nucleated 
cells and clonogenic cells; these results are similar to those obtained in previous 
experiments.  Fig.  S b  shows  the  distributions  obtained  when  cells  from  the 
fractions were tested for their capacity to support the generation of new clono- 
genie  cells.  The  recoveries  of blast  progenitors  when  intact  cells  only  were 
cultured and  when  5  X  l0 "~ unseparated  cells were included are shown  in  the 
figure  as  dotted  lines.  It  is  evident  that  the  fractions  differed widely in  their 
capacity to stimulate blast  progenitor growth.  However, maximum  stimulation 
was  seen  in  regions  of  the  gradient  that  contained  the  largest  numbers  of 
nucleated  cells.  Thus,  in  addition  to  showing  heterogeneity,  the  separation 
experiments provided  evidence  that  the  majority  of blast  cells  were  active  in 
providing support for growth. 
Blast Cell Fractionation.  If the role of blast cells in supporting growth depends NARA  AND  McCULLOCH  1439 
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FIGURE  3.  Fractionation  of blasts  by velocity sedimentation.  Blasts  were separated,  and  the 
numbers of nucleated  cells (O) and clonogenic  cells (O) per fraction  were counted  (a).  5  x  10  5 
cells/ml from each fraction  were irradiated and added to a suspension culture of 5  ×  10  5 intact 
cells/nd.  The  recovery  of clonogenic  cells  is  shown  in  b.  The  control  consisted  of  5  ×  l0 s 
intact cells cultured with  5  x  l0 s irradiated  unfractionated  cells. Values for cultures above the 
upper  dotted  line  indicating  this  control  were  enriched  for  feeding  function.  The  second 
control is the recovery of clonogenic cells in the absence of added irradiated ceils (lower dotted 
line). 
upon  cell contact,  this contact  might  be a  function  of cell  membranes.  To test 
this hypothesis, cells from two patients were fractionated as described in Materials 
and  Methods.  Then,  the  three  fractions,  consisting  respectively  of membranes, 
nuclei,  and cytoplasm,  were tested  for their capacity  to promote  growth of 1.5 
x  10 ~ intact cells in suspension culture. The fractions were added to the cultures 
in amounts equivalent to 1.5 x  106 cells; that number of irradiated, nondisrupted 
cells served as a positive control. The data are given in Table  I. It is evident that 
the  membrane  fraction  was  almost  equivalent  to  intact  cells  in  capacity  to 
stimulate  the  production  of clonogenic  progenitors.  In  contrast,  fractions  con- 
taining principally nuclei and cytoplasm were almost inactive. 
Any further study of the membrane effect would require a quantitative  assay. 
Accordingly,  we added varying concentrations  of membrane fractions to a small 
number  of target  cells (3  X  105 cells/dish);  to observe the effects of membrane 
specifically,  HTB9-CM  was not added.  The data  from a typical experiment  are 
shown in  Fig.  4.  It is evident  that the yield of clonogenic  progenitors  increased 
linearly with the addition  of membrane fraction until a plateau was reached at a 
level of membrane  equivalent  to 6  x  106 cells/dish. 
Specificity.  The  availability  of  a  quantitative  assay  for  membrane  function 1440  LEUKEMIC  MEMBRANES STIMULATE GROWTH 
TABLE  I 
Comparison of Supportive Activity of lrradiated Cells and Cellular 
Components on Blasts'  Growth 
Addition to intact  Recovery of clonogenic cells/dish 
blasts in suspension  Patient 1  Patient 2 
Irradiated cells  13,926 -+ 1,907  114,405 __- 12,499 
Membranes  13,058 + 503  112,092 --- 9,759 
Nuclei  6,509 +  1,118  84,669 + 5,635 
Cytoplasm  5,029 + 666  91,776 + 7,296 
None  4,233 -  758  75,240 + 3,510 
1.5 X 106 intact blasts were cultured in suspension.  1.5 x  106 irradiated 
blasts or cell components derived from  the same number of blasts were 
added, and the recovery of clonogenic cells was determined. 
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FIGURE 4.  Titration of cell membranes for their capacity to promote the growth  of blast 
progenitors.  Varying concentrations of membrane fractions were added to a small number (3 
x  10  h cells/dish) of autologous  blasts in suspension culture without other growth promoters. 
The recovery of clonogenic cells was assessed. The yield of clonogenic progenitors increased 
linearly with the addition of membrane fraction  until a plateau  was reached  at a membrane 
equivalent to 6 x  106 cells/dish. The recovery  of clonogenic cells was 696  -t- 169, 2,978  + 
346, or 8,877 --+ 970 when 2.7 ×  106 irradiated cells, HTB9-CM, or both irradiated cells and 
HTB9-CM were added to the culture, respectively. 
made it feasible to examine the issue of specificity, since homologous cells under 
test did not enter the calculation of the yield of clonogenic cells. Fig. 5  contains 
the results of two experiments. In each, different patients provided target cells. 
It is evident that those of patient A  had a  higher basal blast progenitor plating 
efficiency than  those  of patient  B.  In  both  instances, membrane  preparations 
from  autologous  blasts  were  effective  stimulators,  in  a  dose-related  fashion. 
Further,  homologous  blast  membrane  preparations  were  also  active.  In  the 
experiment shown at the top, the homologous membrane preparation was a  less 
effective stimulator than the autologous preparation; however, it is evident that 
the target cells, rather than the membrane preparations, are the major determi- 
nants of the extent of response. Thus, cells of patient A cultured with a membrane NARA  AND  McCULLOCH  1441 
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FIGURE 5.  Data from two experiments designed to test the specificity of the stimulation of 
blast progenitor growth by membrane preparations.  Patient-to-patient variation is apparent 
by comparing top to bottom. In both, autologous and homologous AML blasts were effective 
stimulators. In contrast, controls, obtained from cells of normal marrow, ALL blasts, or CLL 
lymphocytes, were inactive. The effect of membrane preparations from cells of Patient C on 
autologous targets is shown in Fig. 4, where the response is similar to that seen for homologous 
targets shown here.  Top: autologous cells (patient A) (0); homologous cells (patient B) (O); 
normal marrow cells (&); ALL blast cells (A). Bottom: autologous cells (patient B) (O); homolo- 
gous cells (patient C) (©); CLL leukemic cells (I--1). 
preparation from patient B (top) yielded many more blast progenitors than patient 
B targets stimulated by an autologous membrane preparation (bottom). 
In  both  experiments,  control  membrane  preparations,  derived  either  from 
normal marrow, ALL blasts, or CLL lymphocytes, were inactive. Thus, the data 
provide preliminary evidence that the stimulation of blast progenitor growth in 
suspension cultures by membrane preparations may have AML specificity. 
Discussion 
In  patients  with  AML,  blast  cells  grow  without  apparent  restraint;  their 
numbers  can  only  be  controlled  by  cytotoxic  chemotherapy.  In  contrast,  in 
culture, the proliferation of AML blasts depends on a number of factors. These 
include the usual nutrients  supplied by fetal calf serum and a-MEM. Of greater 
interest, diffusable growth factors are needed both for colony formation in viscid 
cultures and  blast progenitor  self-renewal in  suspension.  For exponential  blast 
cell expansion in suspension cultures, there is an additional requirement for cell- 
cell contact. 
In  this  paper,  we  have  provided  evidence  that  growth  promotion  by  cell 
contact  may be a  function  of one  or  more  components of cell  membranes  or 1442  LEUKEMIC MEMBRANES STIMULATE GROWTH 
microsomes. The cell fractionation experiments showed that suspensions con- 
taining membranes were  much more effective in promoting blast cell  growth 
than fractions enriched for nuclei or fluid cytoplasm. The observations that the 
membrane-associated cellular function was distributed heterogeneously among 
blast cells, and the preliminary finding of AML blast specificity combine to make 
it unlikely that blast membranes were acting passively to protect cells.  Rather, 
the data encourage us to suggest the presence of a defined membrane structure, 
perhaps with the characteristics of a receptor. 
The  relationship  between  blast  cell  membrane-associated  structures  and 
growth factors from media conditioned by HTB9 cells or normal mononuclear 
cells  is  unclear.  These  experiments  indicate  that  neither  source  of  growth 
stimulation can  substitute  for  the  other  (see  Fig.  1).  In  normal  hemopoiesis, 
where molecular clones have been obtained for growth factors, these have been 
found to  be  unrelated products  of single genes  (9-11).  It  is also  known that 
membrane-bound receptors may be encoded by oncogenes, providing a possible 
link between the malignant behaviour of AML blasts and membrane-associated 
structures promoting growth. Further, structural relationships have been found 
between the cell receptor for low density lipoprotein and a precursor molecule 
for epidermal growth factor (EGF); these data may mean that an EGF precursor 
molecule may be a membrane component (12). This is, of course, reminiscent of 
lymphopoeisis, where immunoglobulin molecules serve both as receptors on B 
cells and secreted functional products. 
Resolution of these uncertainties will require analysis of membrane-associated 
and cell-secreted growth factors at both the amino acid and nucleotide level. 
Fortunately, the methods for such studies are now available. 
In  conclusion, AML blasts  provide a  readily available source of clonal (13) 
human leukemic cells that may have many of the regulatory features character- 
istic  of the malignant phenotype. AML blast cells  have the advantage over cell 
lines that findings obtained with them may be correlated with the clinical course 
of patients (14).  It is even possible that regulatory mechanisms, discovered using 
the methods of cellular and molecular biology, may prove accessible targets for 
novel therapies. 
Summary 
The blast cells of acute myeloblastic leukemia (AML) may be considered as a 
renewal population, maintained by blast stem cells  capable of both self-renewal 
and the generation of progeny with reduced or absent proliferative potential. 
Blast progenitor renewal is manifested in suspension culture by an exponential 
increase in clonogenic cells.  This growth requires that two conditions be met: 
first, the cultures must contain growth factors in  media conditioned either by 
phytohemagglutinin (PHA)-stimulated mononuclear leukocytes (PHA-LCM), or 
by cells  of the continuous bladder carcinoma line HTB9 (HTB9-CM). Second, 
the cell density must be  maintained at  10 6 blasts/ml; this may be achieved by 
adding irradiated cells  to smaller numbers of intact blasts.  We are  concerned 
with the mechanism of the feeding function. We present evidence that (a) cell- 
cell contact is required. (b) Blasts are heterogeneous in respect to their capacity 
to  support  growth.  (e)  Fractions  containing membranes  from  blast  cells  will NARA  AND  McCULLOCH  1443 
substitute  for intact cells in promoting the  generation  of new blast progenitors 
in  culture.  (d)  This  membrane function  may be specific for  AML blasts,  since 
membranes from blasts of lymphoblastic leukemia or normal marrow cells were 
inactive. 
Received  for publication lO July 1985. 
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